FindTrial
Sign In

Linagliptin 5 mg tablets,Trajenta 5 mg tablets

3 trials

Sponsors

Bio-innova and Synchron.Co.,Ltd, T. MAN PHARMA COMPANY LIMITED, Thailand, Bio-innova Co., Ltd.

Conditions

Healthy subjects Bioequivalence Linagliptin 5 mg tabletsHealthy subjects Linagliptin BioequivalenceHealthy volunteers, A Bioequivalence safety study Bioequivalence Linagliptin Tablet 5 mg

Phase 1

A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Linagliptin 5 mg tablets relative to Trajenta 5 mg tablets in healthy Thai volunteers under fasting condition
Active, not recruitingTCTR20210706001
Bio-innova and Synchron.Co.,LtdHealthy subjects Linagliptin Bioequivalence
Start: 2021-11-05Target: 36Updated: 2026-08-03
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Linagliptin 5 mg tablets relative to Trajenta 5 mg tablets in healthy Thai volunteers under fasting condition
Active, not recruitingTCTR20220406003
T. MAN PHARMA COMPANY LIMITED, ThailandHealthy subjects Bioequivalence Linagliptin 5 mg tablets
Start: 2022-08-04Target: 26Updated: 2026-08-03
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Linagliptin 5 mg tablets relative to Trajenta 5 mg tablets in healthy Thai participants under fasting condition
Active, not recruitingTCTR20251021005
Bio-innova Co., Ltd.Healthy volunteers, A Bioequivalence safety study Bioequivalence Linagliptin Tablet 5 mg
Start: 2025-12-18Target: 40Updated: 2026-08-03